Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Neuroendocrine 1

Interventions

Cisplatin 4 Etoposide 3 atezolizumab 2 Drug Therapy 2 Carboplatin 2 tivozanib 1 repotrectinib 1 lutetium Lu 177 dotatate 1 durvalumab 1 dostarlimab 1 belinostat 1 Somatostatin 1 Paclitaxel 1 Nivolumab 1 Neoadjuvant Therapy 1 Magnetic Resonance Imaging 1 Ipilimumab 1 FOLFOXIRI protocol 1 EC regimen 1 DLL3 protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Neuroendocrine × DLL3 protein, human × Clear all

NCT06893783 2026-04-13

DeLLight

Asan Medical Center

Phase 2 Recruiting

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡